Rotech Healthcare Responds to FDA Warning Letter (Business Wire via Yahoo! Finance)
ORLANDO, Fla.----Aug. 14, 2006--Rotech Healthcare Inc. today reported that on August 10, 2006, it received a warning letter from the Food and Drug Administration relating to its subsidiary, Pulmo-Dose, Inc.

Ceragenix Pharmaceuticals Initiates EpiCeram(R) Clinical Trial; EpiCeram(R) to Be Compared to Mid-Strength Steroid in (RedNova)
Ceragenix Pharmaceuticals, Inc., a biopharmaceu